Practical guide
How to Read a Peptide Certificate of Analysis (CoA)
A direct explanation of what a CoA confirms, what it cannot confirm, and how to identify which quality indicators actually matter when evaluating a peptide supplier.
What Is a Certificate of Analysis?
A Certificate of Analysis (CoA) is a document issued by an analytical laboratory confirming the identity and purity of a compound. For research peptides, it is the primary quality document used to evaluate whether a supplier's product meets basic research-grade standards. A CoA should be issued by a third-party laboratory independent from the supplier; an in-house CoA signed off by the same company selling the product is not meaningful as an independent quality check.
Understanding what a CoA actually measures, and what it cannot measure, is essential before using it to make sourcing decisions.
What a CoA Confirms
A standard peptide CoA will typically confirm three things:
Identity. HPLC (High-Performance Liquid Chromatography) and/or MS (Mass Spectrometry) confirm that the compound is what it is labelled as. MS confirms the correct molecular mass; HPLC confirms the retention time and peak profile consistent with the reference compound.
Purity percentage. HPLC quantifies what fraction of the detectable material is the target compound versus impurities, truncated sequences, or degradation products. A result above 98% is the standard threshold for research-grade peptides. Results between 95% and 98% are below this threshold. Results below 95% indicate significant impurity content.
Total amount (mg). Gravimetric analysis or HPLC-based quantification confirms the total content of the target compound in the vial. This is relevant for calculating actual dose concentrations after reconstitution.
What a CoA Does NOT Confirm
This is where most misunderstandings occur. A CoA is a chemical document, not a biological one.
Biological activity. Confirming chemical identity and purity does not confirm that the peptide will behave as expected in biological systems. A peptide can be chemically pure and structurally intact while failing to bind its intended receptor or produce the effects described in research literature.
Sterility. Standard CoAs do not include sterility testing. Endotoxin (pyrogen) testing and bioburden testing are separate analytical procedures and are rarely included in commercial peptide CoAs. A high-purity CoA from a supplier does not confirm that the product is free of bacterial endotoxins or microbiological contamination.
Correct folding. HPLC and MS confirm the primary sequence and molecular mass. They do not confirm tertiary or quaternary structure. For most research peptides, which are short linear sequences, correct folding is less of a concern than for larger proteins, but it remains a distinction worth noting.
In vivo efficacy. Chemical identity is not equivalent to functional potency. The CoA is the starting point for quality evaluation, not the endpoint.
Heavy Metal Panels: Marketing or Meaningful?
Heavy metal and arsenic panels are largely a marketing feature, not a meaningful quality differentiator for research peptides.
The concentrations at which heavy metals are typically detected in peptide analytical panels are in the parts-per-billion (ppb) range. At the quantities involved in research peptide dosing, these trace concentrations have no physiological relevance. The arithmetic simply does not produce meaningful exposure levels.
The actual quality indicators are HPLC purity and MS identity confirmation. These are the tests that tell you whether the compound is what it claims to be and whether it is present at a meaningful purity level. A supplier who leads with heavy metal panels while omitting HPLC chromatogram data, or who charges a significant premium for metal panel CoAs, is directing attention toward a low-signal metric and away from the tests that matter.
What to Actually Look For in a Supplier CoA
| What to check | Why it matters |
|---|---|
| HPLC chromatogram included, not just a purity number | Lets you assess peak shape and impurity profile directly. A number without the underlying chromatogram cannot be independently verified and is significantly less informative. |
| MS confirmation present | Confirms molecular identity by mass. HPLC alone confirms purity, not identity. Both together are required to confirm the compound is what it claims to be at a meaningful purity level. |
| Purity above 98% | The research-grade threshold. Below 98% introduces an uncontrolled impurity variable into any protocol. Below 95% is a significant concern. |
| Third-party lab name visible | An in-house CoA issued by the same entity selling the product is not an independent quality check. The lab name and ideally a report number should be present and verifiable. |
| Lot or batch number matches vial | A CoA for a different batch does not reflect the quality of the product you received. Lot traceability is a basic requirement for any meaningful quality document. |
| Test date recent (within 12 months) | A CoA dated more than 12 months ago may not reflect the condition of current stock. Peptides degrade over time; a historic CoA for a batch that has since been stored, shipped, and restocked provides limited assurance about the current product. |
Frequently Asked Questions
What does HPLC purity mean on a peptide CoA?
HPLC purity is the percentage of the total peak area in a chromatogram that corresponds to the target compound. A purity of 98% means that 98% of the detectable material is the intended peptide. The number alone is less informative than seeing the actual chromatogram, which shows peak shape and whether impurity peaks are well-separated or clustered near the target.
Is 95% purity acceptable for research peptides?
95% is below the 98% threshold considered research grade. Whether it matters depends on what the 5% impurity fraction represents, but sourcing from suppliers who cannot consistently meet 98% introduces an uncontrolled variable into any protocol. For most research contexts, 98% or above is the appropriate standard.
Why do some suppliers not show HPLC chromatograms?
Showing only a purity percentage without the chromatogram is a significant red flag. A percentage can be reported selectively; the raw chromatogram cannot be easily manipulated and lets a knowledgeable buyer assess the data independently. Suppliers who omit chromatograms may be obscuring poor peak shapes, closely eluting impurities, or samples that were never properly tested. Always request the full chromatogram if it is not provided.
What is the difference between HPLC and MS on a CoA?
HPLC measures purity by separating sample components and quantifying each peak by area. MS confirms molecular identity by measuring the mass-to-charge ratio of ions. A compound can pass MS (correct mass) while failing HPLC (low purity), or pass HPLC (high purity peak) while MS reveals the mass does not match the intended compound. Both tests together provide identity and purity confirmation; either alone is incomplete.
Key Takeaways
- A CoA confirms identity (HPLC and MS), purity percentage (HPLC), and total amount (gravimetric or HPLC quantification).
- A CoA does not confirm sterility, biological activity, correct folding, or in vivo efficacy.
- 98% HPLC purity is the research-grade threshold. Anything below 95% is a significant concern.
- Always request the full HPLC chromatogram, not just a purity number. The chromatogram cannot be easily manipulated; a number alone can.
- MS confirmation is required alongside HPLC to confirm both identity and purity.
- Heavy metal panels are a marketing feature with no meaningful relevance at research peptide dosing quantities. HPLC and MS are the tests that matter.
- The lab name must be visible and the CoA lot number must match the vial. An in-house CoA is not an independent quality check.